Sanofi India Limited has announced its Board of Directors meeting scheduled for Tuesday, August 4, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results for the quarter and half-year ended June 30, 2026. The company also confirmed that the trading window will remain closed from July 1, 2026, to August 6, 2026, inclusive.
Sanofi India Board Meeting Announcement
Sanofi India Limited has officially announced that its Board of Directors will convene for a meeting on Tuesday, August 4, 2026. This significant meeting will focus on the crucial task of reviewing and approving the company’s Unaudited Financial Results for the financial period ending June 30, 2026. This includes results for both the second quarter and the first half of the fiscal year.
Trading Window Closure Details
In conjunction with the upcoming financial results announcement, Sanofi India Limited has also provided an update regarding its trading window. The company has confirmed that the trading window for its stakeholders will be closed from Wednesday, July 1, 2026, until Thursday, August 6, 2026. This closure, which encompasses both the start and end dates, is standard practice during the period leading up to and immediately following the release of financial information.
Shareholders and the investment community are advised to take note of these important dates as Sanofi India Limited prepares to disclose its latest financial performance.
Source: BSE
